An Exploration of Genetic Testing for Prostate Cancer Susceptibility

NCT00997464 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2009-10-19

No results posted yet for this study

Summary

Study of the factors that affect interest in - and uptake of - genetic testing for variants that predispose to prostate cancer from the perspective of the patient.

Conditions

Sponsors & Collaborators

  • Institute of Cancer Research, United Kingdom

    collaborator OTHER
  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Dr Rosalind Eeles · Institute of Cancer Research, United Kingdom

Eligibility

Min Age
40 Years
Max Age
69 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00997464 on ClinicalTrials.gov